as on September 13, 2025 at 1:29 am IST
Day's Low
Day's High
0.14%
Downside
4.48%
Upside
52 Week's Low
52 Week's High
27.03%
Downside
890.90%
Upside
Check Mersana Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$37.3M
EPS (TTM)
-1.86
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-1.78
Industry PE ratio
-3.773885542168675
P/B Ratio
0PEG Ratio
0EBITDA
-70.6M
Revenue (TTM)
34.8M
Profit Margin
-212.94%
Return On Equity TTM
3851600.00%
Track how Mersana Therapeutics Inc P/E has moved over time to understand its valuation trends.
Mersana Therapeutics Inc in the last 5 years
Lowest (0.00x)
September 13, 2025
Industry (-3.77x)
September 13, 2025
Today (-1.78x)
September 13, 2025
Highest (0.00x)
September 13, 2025
Today’s Price to Earnings Ratio: -1.78x
Compare market cap, revenue, PE, and other key metrics of Mersana Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $37.3M | -98.4% | -1.78 | -212.94% | |
BUY | $61.1B | 280.5% | -505.15 | -12.96% | |
NA | $37.7B | NA | NA | -3.89% | |
BUY | $101.2B | 54.04% | 28.08 | 31.86% | |
BUY | $59.4B | 2.03% | 14.11 | 31.37% |
The Mersana Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Mersana Therapeutics Inc investment value today
Current value as on today
₹18,675
Returns
Returns from Mersana Therapeutics Inc Stock
Dollar Returns*
₹5,139 (+5.14%)
Based on 15 analysts
80.00%
Buy
20.00%
Hold
0.00%
Sell
Based on 15 analysts, 80% of analysts recommend a 'BUY' rating for Mersana Therapeutics Inc. Average target price of $28.29
Get share price movements and forecasts by analysts on Mersana Therapeutics Inc.
What analysts predicted
74.76%UPSIDE
Target Price
$28.29
Current Price
$7.14
Analyzed by
15 Analysts
Target
$28.29
Mersana Therapeutics Inc target price $28.29, a slight upside of 74.76% compared to current price of $7.14. According to 15 analysts rating.
Search interest for Mersana Therapeutics Inc Stock has decreased by -83% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, 2.75M → 3.05M (in $), with an average increase of 9.9% per quarter
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 125.6% return, outperforming this stock by 221.7%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 162.2%
Price Dip
In the last 3 months, MRSN stock has moved down by -22.2%
Profit Down
Netprofit is down for the last 4 quarters, -11.50M → -24.29M (in $), with an average decrease of 31.5% per quarter
Organisation | Mersana Therapeutics Inc |
Headquarters | 840 Memorial Drive, Cambridge, MA, United States, 02139 |
Industry | Health Technology |
CEO | Dr. Martin H. Huber M.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Mohan Bala Ph.D. | Senior VP & Chief Development Officer |
Mr. Ashish Mandelia | VP & Chief Accounting Officer |
Mr. Jason Fredette | Senior Vice President of Investor Relations & Corporate Communications |
Mr. Chuck Miller | Senior Vice President of Regulatory Affairs |
Mr. Mikhail Papisov Ph.D. | Co-Founder |
Dr. Marc Damelin Ph.D. | Exe. Director and Head of Biology, Oncology, Antibody-Drug Conjugate ADC Discovery & Develop. |
Dr. Martin H. Huber M.D. | President, CEO & Director |
Mr. Brian C. DeSchuytner | Senior VP, CFO & COO |
Dr. Timothy B. Lowinger Ph.D. | Senior VP and Chief Science & Technology Officer |
Ms. Alejandra Veronica Carvajal J.D. | Senior VP, Secretary & Chief Legal Officer |
Mersana Therapeutics Inc share price today is $7.14 as on at the close of the market. Mersana Therapeutics Inc share today touched a day high of $7.46 and a low of $7.13.
Mersana Therapeutics Inc share touched a 52 week high of $70.75 on and a 52 week low of $5.21 on . Mersana Therapeutics Inc stock price today i.e. is closed at $7.14,which is 89.91% down from its 52 week high and 37.04% up from its 52 week low.
Mersana Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Mersana Therapeutics Inc (MRSN) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Mersana Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Mersana Therapeutics Inc share’s latest price of $7.14 as on September 13, 2025 at 1:29 am IST, you will get 1.4006 shares of Mersana Therapeutics Inc. Learn more about
fractional shares .
Mersana Therapeutics Inc stock has given -98.4% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?